06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 26.36
+1.62%Forward multiples
Based on analyst estimates
- P/E forward
- 41.26x
- P/E 2026E
- 67.20x
- P/E 2027E
- 24.01x
- P/E 2028E
- 11.96x
- P/S forward
- 6.21x
Trailing multiples
Trailing twelve months
- P/E TTM
- 140.20x
- PEG TTM
- 0.58x
- Price / book
- 1.12x
- Price / sales
- 4.54x
- Price / cash flow
- 138.37x
Enterprise value
- Enterprise value
- HKD 5.5B
- EV / sales
- 3.84x
- EV / EBITDA
- 123.27x
- EV / EBIT
- -82.98x
- Market cap
- HKD 6.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026